Bradford T Whitmore Ultralife Corp (ULBI) insider trading activity

Bradford T Whitmore is Director of ULTRALIFE CORP. Currently has a direct ownership of 1.23 Million shares of ULBI, which is worth approximately $10.3 Million. The most recent transaction as insider was on Dec 08, 2023, when has been sold 7,000 shares (Common Stock) at a price of $7.19 per share, resulting in proceeds of $50,330. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.23M

0% 3M change

3.46% 12M change

Total Value Held $10.3 Million

BRADFORD T WHITMORE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 08 2023	BUY Open market or private purchase	$50,330 $7.19 p/Share	7,000 Added 0.57%	1,226,842 Common Stock
Dec 06 2023	BUY Open market or private purchase	$60,629 $6.83 p/Share	8,877 Added 0.72%	1,219,842 Common Stock
Nov 29 2023	BUY Open market or private purchase	$78,831 $7.34 p/Share	10,740 Added 0.88%	1,210,965 Common Stock
Nov 28 2023	BUY Open market or private purchase	$79,012 $7.08 p/Share	11,160 Added 0.92%	1,200,225 Common Stock
Nov 27 2023	BUY Open market or private purchase	$22,784 $7.12 p/Share	3,200 Added 0.27%	1,189,065 Common Stock
Nov 01 2023	BUY Open market or private purchase	$8,261 $7.51 p/Share	1,100 Added 0.09%	1,185,865 Common Stock
Oct 31 2023	BUY Open market or private purchase	$19,162 $7.37 p/Share	2,600 Added 0.22%	1,184,765 Common Stock
Oct 30 2023	BUY Open market or private purchase	$71,603 $7.04 p/Share	10,171 Added 0.85%	1,182,165 Common Stock
Sep 15 2023	BUY Open market or private purchase	$38,345 $10.25 p/Share	3,741 Added 0.32%	1,171,994 Common Stock
Sep 14 2023	BUY Open market or private purchase	$16,560 $10.35 p/Share	1,600 Added 0.14%	1,168,253 Common Stock
Sep 13 2023	BUY Open market or private purchase	$56,703 $10.02 p/Share	5,659 Added 0.48%	1,166,653 Common Stock
Jun 14 2023	BUY Open market or private purchase	$167,971 $4.97 p/Share	33,797 Added 2.83%	1,160,994 Common Stock
Jun 13 2023	BUY Open market or private purchase	$167,000 $5.0 p/Share	33,400 Added 2.88%	1,127,197 Common Stock
Jun 12 2023	BUY Open market or private purchase	$63,252 $4.72 p/Share	13,401 Added 1.21%	1,093,797 Common Stock
Jun 02 2023	BUY Open market or private purchase	$26,241 $4.4 p/Share	5,964 Added 0.55%	1,080,396 Common Stock
Jun 01 2023	BUY Open market or private purchase	$87,669 $4.33 p/Share	20,247 Added 1.85%	1,074,432 Common Stock
May 31 2023	BUY Open market or private purchase	$30,884 $4.28 p/Share	7,216 Added 0.68%	1,054,185 Common Stock
May 30 2023	BUY Open market or private purchase	$27,885 $4.29 p/Share	6,500 Added 0.62%	1,046,969 Common Stock
May 11 2023	BUY Open market or private purchase	$82,644 $4.08 p/Share	20,256 Added 1.91%	1,040,469 Common Stock
May 10 2023	BUY Open market or private purchase	$16,035 $4.03 p/Share	3,979 Added 0.39%	1,020,213 Common Stock
May 09 2023	BUY Open market or private purchase	$18,075 $3.97 p/Share	4,553 Added 0.45%	1,016,234 Common Stock
Mar 13 2023	BUY Open market or private purchase	$58,355 $4.07 p/Share	14,338 Added 1.4%	1,011,681 Common Stock
Mar 10 2023	BUY Open market or private purchase	$40,905 $4.05 p/Share	10,100 Added 1.0%	997,343 Common Stock
Mar 09 2023	BUY Open market or private purchase	$22,637 $4.07 p/Share	5,562 Added 0.56%	987,243 Common Stock
Dec 16 2022	BUY Open market or private purchase	$28,656 $3.98 p/Share	7,200 Added 0.73%	981,681 Common Stock

Also insider at

NANX

NANOPHASE TECHNOLOGIES Corp Basic Materials

> 10% Shareholder

CLSD

Clearside Biomedical, Inc. Healthcare

> 10% Shareholder

BTW